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The method of choice for analysis of drugs in multi-component preparations 
is chromatographic based technique such as high performance liquid 
chromatography (HPLC). A liquid chromatographic method was applied for 
the analysis paracetamol (PCT), guaiphenesin (GG), chlorpheniramine 
maleate (CTM) and phenylpropanolamine HCl (PPA) using three different 
system as described in the USP XXXVI/NF 31. The method depends on a 
separation on  reversed-phase C8, C18 and Phenyl column for analysis PCT, 
GG, and CTM-PPA respectively with mobile phase water-methanol-acetic 
acid glacial (79:20:1) for PCT, water-methanol-acetic acid glacial (60:40:1,5) 
for GG and methanol-water (60:40) containing 0.34 g of monobasic 
potassium phosphate, 0.05 g of triethylamine hydrochloride, 0.25 g of 
sodium lauryl sulfate, and 0.1 mL of phosphoric acid in each 100 mL for CTM-
PPA. Quantitation was achieved with UV detection at 280, 276 and 214 nm 
respectively for PCT, GG, and CTM-PPA based on peak area. The methods 
were validated in terms of system suitability test, specificity, precision, 
accuracy, linearity, and the results were found to be satisfactory. 
 





Paracetamol (PCT), Guaiphenesin(GG),  
Chlorpheniramine maleate (CTM) and 
Phenylpropanolamine Hydrochloride (PPA) (Figure 1) 
are active pharmaceutical ingredients frequently 
combined and widely used in several pharmaceutical 
preparations, especially in cold and cough 
formulation. PCT is a popular antipyretic and 
analgesic agent (Hardman et.al., 1996). In some 
countries, it is one of the most used medicines, as an 
alternative to acetylsalicylic acid (aspirin).  GG is an 
expectorant used for treatment of productive 
cough.  
CTM is a powerful first-generation alkyl amine 
antihistamine, H1-receptor antagonist, widely used 
for symptomatic relief of common cold and allergic 
rhinitis, with weak sedative properties, while PPA is 
a nasal decongestan (Redasani et.al, 2013). 
Some analytical methods have been used for 
determination of PCT, GG, CTM and PPA, either 
alone or in combination with other medicines, in 
pharmaceutical products, mostly based on 
chromatographic and electrophoretic techniques. 
Such methods are high performance liquid 
chromatography (Akhtar et.al, 1994; Deconinck 
et.al, 2011), gas chromatography (Harsono et.al, 
2005), FTIR spectrophotometry (Mallah et.al, 2012), 
cyclic voltametry (Teixeira et.al, 2009) and 
derivative spectrophotometry (Deshpande et.al, 
2012). 






Y. Ardiyanti, Sudjadi, S. Riyanto, A. Rohman / J.Food Pharm.Sci (2014), 83-93                                                                                            
 
The objective of this study was to determine 
paracetamol (PCT), guaiphenesin (GG), 
chlorpheniramine maleate (CTM) and 
phenylpropanolamine HCl in cough and cold tablet 
formulation using high performance liquid 
chromatography (HPLC). 
 
2. Materials and Methods 
2.1. Materials 
 The standards of Paracetamol (PCT), 
Guaiphenesin (GG), Chlorpheniramine maleate (CTM) 
and Phenylpropanolamine HCl (PPA) were of Reference 
standard of Indonesian Pharmacopeia and were 
obtained from the National Agency of Drug and Food 
Control, Republic of Indonesia. Distilled water were 
obtained from Brataco Chemical, Indonesia, double 
distilled water were obtained from Otsuka, Indonesia. 
Hydrochloride acid, acetic acil glacial, orthophosphoric 
acid 85%, monobasic potassium hydroxide, triethylamine 
hydrochloride and sodium lauryl sulphate were of pro 
analytical grade, methanol used for solvent and mobile 
phase were of liquid chromatography grade and 
obtained from Merck Chemical, Germany. The tablet 
dosage form was obtained from pharmacy in 
Yogyakarta containing 650 mg PCT, 100 mg GG, 15 mg 
PPA and 2 mg CTM on label claimed in each tablet . 
 
2.2. Determination of Paracetamol (PCT) in cough and 
cold tablet dosage form 
2.2.1 HPLC Condition 
The HPLC separation and quantitation were made 
on HPLC  Shimadzu LC-20AD, SPD-20A, SIL 20AC – SP1 
on a Waters Spherisorb 10 µm C8 column (250 × 4.6 mm 
i.d.). The mobile phase was prepared by mixing double 
distilled water – methanol – acetic acid glacial in ratio of 
79:20:1 (v/v). The flow rate was 1 mL/min. All 
determinations were performed at ambient 
temperature. The injection volume was 20 µL. The 
mobile phase was filtered using 0.45-µm membrane 
filter (Millipore, Milford, MA) and degassed by vacuum 
prior to use. The samples were also filtered using 0.45-
µm disposable filters. The detector was set at 280 nm.  
 
2.2.3 Preparation of Paracetamol standard solution 
Approximately 25 mg of paracetamol reference 
standard were taken and placed in a 25 mL flask. Add 2 
mL of methanol, diluted with 0.1% phosphoric acid, 
sonicated for 10 minutes and then cooled to room 
temperature, diluted with 0.1% phosphoric acid up to the 
mark (standard stock solution). As much as 2.5 mL of 
standard stock solution was put into the 10 mL flask, 
0.1% phosphoric acid was added to the mark, then 
filtered using a filter with a pore size of 0.45 µm (I-A). 
 
2.2.4 Sample Solution  
Not less than 20 of cough and cold tablets 
containing paracetamol were taken then powdered. 
The amount of powder equivalent to approximately 50 
mg of paracetamol, put in a 50 mL flask, added 4 mL of 
methanol, diluted with 30 mL of 0.1% phosphoric acid, 
sonicated 20 minutes and then cooled to room 
temperature, diluted with 0.1% phosphoric acid up to the 
mark (sample stock solution). As much as 2.5 mL of 
sample stock solution was put in 10 mL flask, 0.1% 
phosphoric acid was added up to the mark then filtered 
using a filter with a pore size of 0.45 µm (I-B). 
Replication done for six times. 
 
2.3. Determination of Guaiphenesin (GG) in cough and 
cold tablet dosage form 
HPLC Condition 
The HPLC separation and quantitation were made 
on HPLC  Shimadzu LC-20AD, SPD-20A, SIL 20AC – SP1 
on a Waters X-Bridge 5 µm C18 column (250 × 4.6 mm 
i.d.). The mobile phase was prepared by mixing double 
distilled water – methanol – acetic acid glacial in ratio of 
60:40:1.5 (v/v). The flow rate was 0.7 mL/min. All 
determinations were performed at ambient 
temperature. The injection volume was 20 µL. The 
mobile phase was filtered using 0.45-µm membrane 
filter (Millipore, Milford, MA) and degassed by vacuum 
prior to use. The samples were also filtered using 0.45-
µm disposable filters. The detector was set at 276 nm.  
 
 
     Fig. 1. Chemical structure of (a) paracetamol, (b) guaiphenesin, (c) chlorpheniramine maleat and 
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2.3.1. Preparation of Guaiphenesin standard solution 
Approximately 10 mg of guaiphenesin reference 
standard were taken and placed in a 10 mL flask, added 
with water, sonicated for 10 minutes and then cooled to 
room temperature, diluted with water up to the mark. 
As much as 1 mL of standard stock solution was put into 
the 50 mL flask, added with 22.5 mL methanol, diluted 
with water to the mark, then filtered using a filter with a 
pore size of 0.45 µm (II-A). 
 
2.3.2 Sample Solution  
Not less than 20 of cough and cold tablets 
containing guaiphenesin were taken then powdered. 
The amount of powder equivalent to approximately 100 
mg of guaiphenesin was put in a 50 mL flask, added 
with water, sonicated 10 minutes and then cooled to 
room temperature, diluted with water up to the mark 
(sample stock solution). As much as 1 mL of sample 
stock solution   was  put  in  100 mL   flask,  added  with   
45 mL 
methanol, diluted with water to the mark, then 
filtered using a filter with a pore size of 0.45 µm (II-B). 
Replication done for six times. 
 
2.4. Determination of Chlorpheniramine maleate 
(CTM) and Phenylpropanolamine hydrochloride in 
cough and cold tablet dosage form 
HPLC Condition 
The HPLC separation and quantitation were made 
on HPLC  Shimadzu LC-20AD, SPD-20A, SIL 20AC – SP1 
on a Waters X-Bridge 5 µm Phenyl column (150 × 4.6 mm 
i.d.). The mobile phase was prepared by mixing 
methanol-water (60:40) (v/v) containing 0.34 g of 
monobasic potassium phosphate, 0.05 g of 
triethylamine hydrochloride, 0.25 g of sodium lauryl 
sulfate, and 0.1 mL of phosphoric acid in each 100 mL. 
The flow rate was 1 mL/min. All determinations were 
performed at ambient temperature. The injection 
volume was 20 µL. The mobile phase was filtered using 
0.45-µm membrane filter (Millipore, Milford, MA) and 
degassed by vacuum prior to use. The samples were 
also filtered using 0.45-µm disposable filters. The 
detector was set at 214 nm.  
 
2.4.1. Preparation of Phenylpropanolamine HCl 
standard solution 
Approximately 25 mg of phenylpropanolamine HCl 
reference standard were taken and placed in a 10 mL 
flask. Added with water, sonicated for 10 minutes and 
then cooled to room temperature, diluted with water 
up to the mark (standard stock solution). As much as 1 
mL of standard stock solution was put into the 50 mL 
flask added with 5 mL methanol, diluted with 0.1% 
phosphoric acid to the mark, then filtered using a filter 
with a pore size of 0.45 µm (III-A). 
 
 
2.4.2. Preparation of Chlorpheniramine maleate 
standard solution 
Approximately 3.33 mg of chlorpheniramine 
maleate reference standard were taken and placed in a 
10 mL flask. Added with water, sonicated for 10 minutes 
and then cooled to room temperature, diluted with 
water up to the mark (standard stock solution). As 
much as 1 mL of standard stock solution was put into 
the 50 mL flask added with 5 mL methanol, diluted with 
0.1% phosphoric acid to the mark, then filtered using a 
filter with a pore size of 0.45 µm (III-B). 
 
2.4.3 Preparation of mixed CTM and PPA standard solut      
ion 
As much as 1 mL of CTM and PPA standard stock 
solution was put into the 50 mL flask added with 5 mL 
methanol, diluted with 0.1% phosphoric acid to the mark, 
then filtered using a filter with a pore size of 0.45 µm 
(III-C). 
 
2.4.4. Sample Solution  
Not less than 20 of cough and cold tablets 
containing CTM and PPA were taken then powdered. 
The amount of powder equivalent to approximately 2.5 
mg of PPA, put in a 50 mL flask, added 5 mL of 
methanol, diluted with 30 mL of 0.1% phosphoric acid, 
sonicated 20 minutes and then cooled to room 
temperature, diluted with 0.1% phosphoric acid up to the 
mark then filtered using a filter with a pore size of 0.45 
µm (III-D). Replication done for six times. 
 
2.5. Methods verification System suitability test 
Standard solution of PCT (I-A), GG (II-A) and CTM-
PPA (III-C) repeatedly injected 6 times from the same 
solution. Retention time, peak area and tailing factor 
were recorded then the value of the percent RSD were 
calculated. In general, the good system is expressed by 
RSD ≤ 2% (Snyder et al., 1997). 
 
2.5.1. Specificity 
Specificity test was done by analyzing the HPLC 
chromatograms generated from the system suitability 
test and use the PDA detector to see the peak purity. 
The solution was injected into each HPLC system with 
PDA detector is standard solution, sample solution and 
mixture of standard and sample solution with ratio of 1: 
1. Specificity is indicated by the resolution of analyte 
peaks adjacent peaks in preparation. Generally 
acceptable resolution of ≥ 2 (Snyder et al., 1997). 
Moreover specificity is also determined by using the 
PDA detector to see chromatogram peak purity index 
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2.5.2. Precision 
Precision test was performed by injection of the 
test solution (I-B, II-B, and III-D), the replication is 
performed 6 times. Peak areas were recorded and 
calculated by comparing the peak area of standard from 
system suitability test. The average value and standard 
deviation (SD) and relative standard deviation values 
(RSD) was calculated from the six levels obtained. 
Acceptance values based on the value of precision test 
analyte concentration which RSD value ≤ 1.3% for PCT 
and GG,  RSD value ≤ 1.9% for PPA and RSD value ≤ 2.8% 
for CTM (AOAC, 1998). Average levels of each precision 
test express the level of PCT, GG, CTM and PPA in 
pharmaceutical preparations tested samples. 
 
2.5.3. Accuracy 
Accuracy test was performed by creating a mixed 
solution of standard stock solution and sample stock 
solution concentration levels 80, 90, 100, 110 and 120% 
with a ratio of 3: 7. Replication on each point accuracy 
was done 3 times for the standard solution and three 
different  sample  stock  solution. A  mixture of standard 
 
                  Fig. 2. Chromatograms of paracetamol system suitability test 
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and sample 3:7 is injected into the chromatographic 
system. Peak area were recorded and calculated by 
comparing the standard peak area from system 
suitability test as the measured analyte concentration. 
Percent recovery was calculated by comparing the 
measured analyte concentration to the theoretical 
concentration of the analyte. Percent recovery is said to 
be good if it lies in the range of 98-102% for PCT, 93-103% 
for PPA and 95-105% for CTM (AOAC, 1998). 
 
2.5.4. Linearity 
Linearity is an indicator of the ability of an 
analytical method which shows that the detector 
response is proportional to the concentration of analyte 
in a sample at a particular range of values. Linearity test 
is done by making a solution of the active substance 
concentration levels between 80% to 120% equal with 
accuracy test with 3 times repetition for each 
concentration. Each of the above solution is injected 
into the HPLC system, then created regression equation 
between peak area (y-axis) against concentration (x-
axis) so that the resulting linear regression equation y = 
a + bx, and the value of the correlation coefficient (r)  
was obtained as linearity parameters. Value of the 
correlation coefficient (r) received if ≥ 0,999 (Snyder et 
al., 1997; Miller and Miller, 2010). 
 
2.5.5.Data Analysis 
The level of paracetamol, guaiphenesin, 
chlorpheniramine maleate and phenylpropanolamine HCl 
in tablet dosage form and the correlation between actual 
values of these drugs are calculated and performed using 
Microsoft Office Excel 2007. 
 
3. Results and Discussion 
Analysis of PCT, GG, CTM and PPA conducted with 
3 separate HPLC system. Verification methods of 3 such 
systems needs to be done to look at the ability of 
laboratories to apply the method of analysis. 
Verification method of GG has been carried out by 
laboratory analysts so that researchers only verifying 
the assay method of PCT, CTM and PPA in tablet dosage 
form. 
 
3.1.   System suitability test 
Figure  2, 3 and 4 shows the chromatograms of 
PCT, GG, CTM and PPA system suitability test in its each 
sytem condition. Tables 1, 2 and 3 respectively present 
the results of PCT, GG and CTM-PPA system suitability 
datas. The table provides information that HPLC system 
assay stated good system as the all RSD values ≤ 2.0%. 
 
3.2.  Specificity 
In this study, the determination of the specificity are 
carried out using UV-PDA detector. Uv spectrum profiles 
are shown in a certain retention time, as well as 
information on the purity of the chromatogram can be 
seen by the peak purity index values (peak purity index). 
Methods assessed selective when approaching the peak 
purity index of 1.00 (Ahuja and Dong, 2005). 
 
        Fig. 4. Chromatograms of chlorpheniramine maleate and phenylpropanolamine HCl  









Y. Ardiyanti, Sudjadi, S. Riyanto, A. Rohman / J.Food Pharm.Sci (2014), 83-93                                                                                            
 
 
Fig. 5. UV spectra profile of paracetamol on the 




Fig. 6. UV spectra profile of chlorpheniramine maleate 




Fig. 7. UV spectra profile of phenylpropanolamine HCl 
on the specificity test using a PDA detector 
In determining the specificity of paracetamol, 
specific wavelengths obtained at 228.82; 232.09 and 244 
nm. Paracetamol peak purity index is 0.999987 indicating 
that the method is selective. Profile paracetamol uv-PDA 
spectra can be seen in Figure 5. In the determination of 
chlorpheniramine maleate-phenylpropanolamine HCl, 
specific wavelengths obtained at 223.89; 243.27 and 
262.61 nm for chlorpheniramine maleate and at 228.69; 
257.72 nm   for   phenylpropanolamine   HCl.    Peak purity  
 
index for chlorpheniramine maleate and 
phenylpropanolamine HCl is 0.999998 and 1.000000 
indicating that the HPLC method is selective for both. Uv-
PDA spectra profile of chlorpheniramine maleate and 
phenylpropanolamine HCl can be seen in Figure 6 and 7. 
Specificity of a method is the method's ability to measure 
certain substances careful and thorough with the other 
components. CTM chromatogram is perfectly separated 
from PPA HCl. The separation is expressed by the value of 
resolution. In this study, the average resolution of the 
CTM and PPA HCl is 32.424. In general, if the good 
resolution is expressed while greater than 2 (Snyder et al., 
1997). Thus the assay method CTM-HCl PPA meets the 
requirements of the resolution. 
 
3.3. Precision 
Precision test was performed with the injection of 
the sample solution and was done 6 times. This test is 
used to look at the ability of the method to analyze 
samples at the same operational conditions within a short 
time. Peak area recorded and calculated by comparing the 
standard peak area on system suitability test. The average 
of the six levels are calculated is 99.71%; 101.07%; 
106.01%; 103.67% respectively for PCT, GG, CTM and PPA 
HCl, and the relative standard deviation (RSD) of PCT, GG, 
CTM and PPA HCl respectively are of 1.17%; 0.79%; 1.43% 
and 1.90% as shown in Table 4. Precision test 
acceptability value based on the value of the 
concentration of the analyte: RSD ≤ 1.3% for PCT and GG; 
RSD ≤ 1.9% for PPA HCl, and RSD ≤ 2.8% for CTM (AOAC, 
1998), so it can be stated that the test precision of this 
method is eligible. Average levels of each precision test 
express the level of PCT, GG, CTM and PPA in 
pharmaceutical preparations tested samples. 
 
3.4.  Accuracy 
Accuracy is parameter of the closeness between the 
results obtained with a particular method of analysis with 
the actual values, represented by the percent recovery. In 
this study, the accuracy test performed at level 5 levels, 
namely 80, 90, 100, 110 and 120% of the analyte with the 
standard addition method with replication 3 times for 
each point. Standard addition method performed by the 
addition of a certain amount of standard into the sample 
solution with a ratio of 3: 7. 
Tables 5, 6 and 7 present the accuracy test data of 
paracetamol, phenylpropanolamine hydrochloride and 
chlorpheniramine maleate. Recovery of paracetamol 
obtained was 98-100% with the acceptance condition 98- 
102% of 100% of the analyte content, 
phenylpropanolamine HCl recovery is 98-100% with the 
acceptance condition 97-103% for the analyte content of 
1% and CTM recovery 98-100% with acceptance condition 
95-105% for the analyte content of 0.1% (AOAC, 1998). 
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Table 1. System suitability test data on paracetamol (PCT) assay method  
No. Retention time (minute) Peak area (uV) Tailing factor 
1 6.984 3865820 0.840 
2 6.969 3868346 0.840 
3 6.962 3868615 0.840 
4 6.958 3869515 0.840 
5 6.954 3869584 0.840 
6 6.950 3871601 0.840 
AV 6.963 3868914 0.840 
%RSD  0.176 0.049 0.021 
 
Table 2. System suitability test data on guaiphenesin (GG) assay method  
No. Retention time (minute) Peak area (uV) Tailing factor 
1 8.700 371262 1.381 
2 8.714 369706 1.380 
3 8.710 370231 1.380 
4 8.707 369862 1.380 
5 8.707 369967 1.379 
6 8.706 370408 1.380 
AV 8.707 370239 1.380 
%RSD  0.053 0.152 0.034 
 
Table 3. System suitability test data on chlorpheniramine maleate (CTM)-phenylpropanolamine HCl (PPA) assay 
method 
No. 
Retention time (minute) Peak area (uV) Tailing factor 
Resolution 
PPA HCl CTM PPA HCl CTM PPA HCl CTM 
1 6.762 31.984 1857187 224847 0.844 0.986 32.323 
2 6.776 31.997 1856179 224632 0.849 0.985 32.407 
3 6.771 31.943 1853783 224668 0.851 0.987 32.296 
4 6.775 32.147 1854667 224769 0.855 0.988 32.410 
5 6.785 32.148 1852752 223400 0.860 0.986 32.421 
6 6.801 32.479 1852996 221914 0.866 0.977 32.589 
AV 6.778 32.116 1854594 224038 0.854 0.985 32.424 
%RSD  0.197 0.615 0.096 0.523 0.929 0.385 0.271 
 
Table 4. Precision test data / data assay of paracetamol (PCT), guaiphenesin (GG), chlorpheniramine maleate (CTM) and 




PCT GG CTM PPA HCl 
1 639.85 102.18 2.15 15.54 
2 647.07 101.75 2.13 15.46 
3 657.76 101.02 2.16 16.11 
4 655.65 100.25 2.09 15.24 
5 651.05 101.05 2.08 15.53 
6 640.29 100.17 2.12 15.41 
Average (mg/tablet) 648.61 101.07 2.12 15.55 
Label claimed (mg) 650 100 2 15 
Average (%)* 99.71 101.07 106.01 103.67 
SD (mg) 7.58 0.80 0.03 0.30 
RSD (%) 1.17 0.79 1.43 1.90 
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Table 5.  Accuracy test results of the paracetamol assay in cough and cold tablet using USP XXXVI (2013) HPLC method 
 
Accuracy Parasetamol 
Analyte level (%) Calculated (µg/mL) Teoritical (µg/mL) Re-covery (%) Ave-rage (%) SD (%) RSD (%) 
80 
197.21 201.05 98.09 
99.38 1.19 1.19 200.53 201.27 99.63 
200.79 199.94 100.43 
90 
221.91 226.18 98.11 
98.98 0.77 0.78 224.73 226.43 99.25 
224.00 224.93 99.59 
100 
246.11 251.31 97.93 
99.20 1.19 1.20 250.04 251.59 99.39 
250.66 249.92 100.30 
110 
272.10 276.44 98.43 
99.34 0.79 0.79 276.05 276.75 99.75 
274.48 274.91 99.84 
120 296.89 301.57 98.45 99.24 0.73 0.74 
 
Table 6. Accuracy test results of the phenylpropanolamine HCl assay in cough and cold tablet using USP XXXVI (2013) 
HPLC method 
Accuracy Phenylpropanolamine HCl 
Analyte level (%) Calculated (µg/mL) Teoritical (µg/mL) Re-covery (%) Ave-rage (%) SD (%) RSD (%) 
80 
40.82 41.02 99.49 
99.58 0.12 0.12 40.89 41.01 99.71 
40.80 41.00 99.53 
90 
45.20 46.12 98.01 
98.59 0.82 0.83 45.37 46.18 98.24 
45.93 46.15 99.53 
100 
50.71 51.26 98.93 
99.17 0.21 0.21 50.93 51.28 99.31 
50.92 51.29 99.27 
110 
54.81 55.92 98.02 
98.30 0.43 0.44 55.28 56.36 98.09 
55.68 56.36 98.80 
120 
59.15 60.30 98.09 
98.27 0.16 0.17 60.48 61.46 98.41 
60.10 61.14 98.31 
 
Table 7. Accuracy test results of the chlorpheniramine maletae assay in cough and cold tablet using USP XXXVI (2013) 
HPLC method 
Accuracy Chlorpheniramine maleate 
Analyte level (%) Calculated (µg/mL) Teoritical (µg/mL) Re-covery (%) Average (%) SD (%) RSD (%) 
80 
5.39 5.48 98.26 
99.00 0.64 0.65 5.45 5.48 99.39 
5.44 5.48 99.35 
90 
6.13 6.16 99.44 
98.92 0.46 0.46 6.09 6.17 98.69 
6.08 6.17 98.62 
100 
6.86 6.85 100.17 
99.73 1.17 1.17 6.74 6.85 98.40 
6.90 6.85 100.62 
110 
7.46 7.47 99.89 
100.01 0.28 0.28 7.52 7.53 99.81 
7.56 7.53 100.33 
120 
8.07 8.06 100.22 
99.97 0.61 0.61 8.15 8.21 99.28 
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3.5.  Linearity 
Linearity test is done by injecting 5 series 
concentrations in the range 80-120% of the expected 
concentration in the preparations, each performed 3 
replication. This linearity is used to determine the 
relationship between the concentration and the analyte 
peak area. Figure 8, 9 and 10 shows the relationship 
between the concentration and peak area of paracetamol, 
chlorpheniramine maleate and phenylpropanolamine HCl 
respectively. Linearity test result in the r value are 0.9999 
(PCT), 0.9997 (PPA HCl) and 0.9999 (CTM). This suggests 
that the method of analysis produces a peak area that is 
proportional to the analyte concentration. 
 
4.   Conclusion 
The assay results obtained using HPLC method were 
convenient, and good coincidence was observed. The 
HPLC method was found to be suitable for the routine 
determination of paracetamol, guaiphenesin, 
chlorpheniramine maleate and phenylpropanolamine HCl 
in tablet dosage form and they do not require any 
separation or extraction procedures. 
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